FeesSafety
Pluang+

Schwab US Dividend Equity ETF remains a Buy with strong dividend growth and diversified healthcare exposure.

Market News
02 Nov 2026, 10:07 WIB
Seeking Alpha
View Source
Neutral
Schwab US Dividend Equity ETF remains a Buy with strong dividend growth and diversified healthcare exposure.

The Schwab US Dividend Equity ETF (SCHD) is recommended as a Buy for the next 12 to 24 months due to consistent dividend growth and robust portfolio diversification. Its healthcare sector allocation has increased to nearly 19%, making it a key driver and risk factor, especially around U.S. policy events. The ETF mitigates concentration risks through quarterly rebalancing and caps on stock and sector weights, maintaining an income-focused profile. The main downside risk is a potential Democratic sweep in upcoming elections, which could impact healthcare holdings, but otherwise, policy risks are manageable and mostly headline-driven.

The Schwab US Dividend Equity ETF (SCHD) shows stability with a price of USD 35.81 and a slight 1-day increase of 0.06% as of Nov 02, 2026 15:21 WIB on Pluang. This modest gain contrasts with its significant healthcare sector allocation of nearly 19%, highlighting the sector's role as both a growth driver and risk factor. With a market cap of $121.09 billion and a typical hold time of 70 days on Pluang, SCHD's performance reflects steady investor interest despite potential policy uncertainties.

More News (SCHD)

SCHD downgraded to Hold, VIG upgraded to Buy as market rotation favors growth over defensive sectors.

SCHD downgraded to Hold, VIG upgraded to Buy as market rotation favors growth over defensive sectors.

The Schwab U.S. Dividend Equity ETF (SCHD) has been downgraded to Hold, while the Vanguard Dividend Appreciation ETF (VIG) is upgraded to Buy due to a shortening market rotation runway. In November, SCHD attracted $27.5 billion inflows, becoming the ...

Analyst Insights
Neutral
12 hours ago
Schwab US Dividend Equity ETF rallies 10% on strong earnings and dividend inflows, with 8% upside potential.

Schwab US Dividend Equity ETF rallies 10% on strong earnings and dividend inflows, with 8% upside potential.

The Schwab US Dividend Equity ETF (SCHD) has rallied about 10% since early October, supported by stronger earnings from key holdings like Texas Instruments and UnitedHealth, as well as inflows into dividend-focused funds. SCHD trades at roughly 18.6 ...

Market News
Bullish
1 day ago
4-Factor Dividend Growth Strategy outperforms SCHD with 14.98% average return focusing on quality and growth.

4-Factor Dividend Growth Strategy outperforms SCHD with 14.98% average return focusing on quality and growth.

The 4-Factor Dividend Growth Strategy, which selects stocks based on free cash flow to debt, dividend growth, return on capital employed, and forward yield, has achieved an average return of 14.98%, outperforming the Schwab US Dividend Equity ETF (SC...

Others
Bullish
4 days ago
SCHD ETF remains a Buy with 2027 catalysts boosting dividends, cash flow, and sector-diverse growth.

SCHD ETF remains a Buy with 2027 catalysts boosting dividends, cash flow, and sector-diverse growth.

The Schwab U.S. Dividend Equity ETF (SCHD) is rated a Buy due to expected catalysts in 2027 that support capital appreciation, strong free cash flow, and dividend growth. Its top holdings, including Texas Instruments, Home Depot, Coca-Cola, and Amgen...

Bullish
4 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App